Table 1. Effect of genotype and APAP on hepatic enzyme activities.
WT | SOD1−/− | |||
---|---|---|---|---|
Substrate | PBS | APAP | PBS | APAP |
Total SOD | 1384±55 | 1154±48* | 15.6±0.8† | 15.7±0.8† |
(50% Formazan dye | ||||
formation rate inhibition | ||||
per mg of protein) | ||||
SOD2 | 12.5±0.15 | 11.0±1.0 | 12.0±0.25 | 10.9±0.55 |
(50% Formazan dye | ||||
formation rate inhibition | ||||
per mg of protein) | ||||
GPX1 | 862±34 | 652±40* | 527±15† | 414±39† |
(Nanomoles of | ||||
glutathione oxidized per | ||||
min per mg of protein) | ||||
Thioredoxin reductase | 27.2±0.97 | 10.0±0.79* | 36.9±1.22† | 14.1±1.53* |
(Nanomoles of | ||||
5′-thionitrobenzoic acid | ||||
formed per min per | ||||
mg of protein) | ||||
Glutathione reductase | 36.3±2.3 | 28.5±1.7 | 38.0±1.4 | 35.3±1.4 |
(Nanomoles of GSSG | ||||
reduced per min | ||||
per mg of protein) | ||||
GST | 3926±188 | 2176±460* | 4577±493 | 5318±118† |
(Nanomoles of S-2,4- | ||||
dinitrophenylglutathione | ||||
formed per min per mg | ||||
of protein) |
*The APAP-treatment effect (P<0.05) as compared with PBS treatment within genotypes.
†The genotype effect (P<0.05) within the same treatment.